Stocks to sell

This year will probably go down as the roughest year for investors since the financial recession in 2008. The S&P 500 has shed more than 20% of its value year-to-date as inflation and interest rates weigh down the equities market. Hence, investors are scrambling to streamline their portfolios. In doing so, they might want to
0 Comments
With stocks still in a bear market, adding dividend stocks may look very appealing right now. Even if the overall market keeps dropping, stocks with steady payouts could still produce positive returns for your portfolio. However, while there are opportunities out there for income-focused investors, there are also plenty of dividend stocks to sell if
0 Comments
This year, consumer stocks have been hammered as inflation lingers at 40-year highs and interest rates rise. The Dow Jones U.S. Consumer Goods Index is down 20% this year as consumers pull back on their spending. However, some consumer-focused companies have performed worse than others. Much worse.  Whether it is due to poor management, failure to adapt
0 Comments
Novavax (NASDAQ:NVAX) stock hasn’t had a great 2022, down 86% since the beginning of the year. The company focuses on products to treat infectious diseases but is definitely best known for its Covid-19 vaccine NVX-CoV2373, also known as Nuvaxovid. There are plenty of other competing vaccines in this category, and Novavax’s shots haven’t been strong sellers
0 Comments
There’s been some drama surrounding Cassava Sciences (NASDAQ:SAVA) recently. First, there was a report stating that the Securities and Exchange Commission, or SEC, cleared Cassava Sciences of charges of manipulating research results. Not long afterward, however, Cassava disputed the legitimacy of that report. These twists and turns in the ongoing story make it difficult to recommend
0 Comments
Sometimes, you just have to let go of a thesis when it’s proven wrong. Stubborn investors might try to average down on microprocessor manufacturer Intel (NASDAQ:INTC) stock. That’s not a wise move to make, though, as even the company’s management had to acknowledge challenging market conditions. If you’re only in it for the dividend payouts, don’t
0 Comments
Over the past two months, sentiment for FuboTV (NYSE:FUBO) stock has gone from “game over” to “game on.” Hitting a new low of $2.32 per share in late July, FUBO stock briefly spiked to above $6 per share in August as the result of an extremely positive response its first investor day presentation. Although this
0 Comments
When a company’s CEO is frustrated, that’s probably not a good sign for investors. Today’s case in point is Palantir Technologies (NYSE:PLTR) stock, which seems to be having difficulty with some government contracts as their timing can be problematic. Furthermore, Palantir’s disappointing forward guidance could easily be a deal-breaker for prospective PLTR stock investors. Don’t get
0 Comments
It is probably the right time for you to think about some marijuana stocks to sell. Marijuana stocks have been a massive downer this year. The selloff in risky stocks has been particularly hard on the marijuana sector. One of the leading funds tracking the sector is the AdvisorShares Pure Cannabis ETF, which has lost
0 Comments
SoFi Technologies (NASDAQ:SOFI) stock has been a disappointment for investors. From the outset, the neo-banking firm was supposed to disrupt the American financial sector. Yet, that vision hasn’t become a reality in the 2020s. Long-term SOFI stockholders are still struggling to break even. Tight central bank monetary policy certainly won’t make things easier for SoFi Technologies. Besides,
0 Comments